Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGRMiddle East and Africa Mobile Cardiac Telemetry (MCT) Market, By Technology (Lead Based, Patch Based), Type (Multi-Channel, Single Channel), Cellular Connection (Wireless (WIFI), Bluetooth (BT)), End User (Home Healthcare, Hospitals, Independent Diagnostic Testing Facility (IDTF), Cardiac Centres, Ambulatory Surgical Centres) – Industry Trends and Forecast to 2030.
Middle East and Africa Mobile Cardiac Telemetry (MCT) Market Analysis and Size
The major factors that are expected to boost the growth of the Middle East and Africa mobile cardiac telemetry (MCT) market in the forecast period of 2023 to 2030 are the rise in the incidence of cardiac disease. Furthermore, the increase in cardiovascular complication is further anticipated to propel the growth of the market. On the other hand, the increase in the price of mobile cardiac telemetry devices is further projected to impede the growth of the mobile Middle East and Africa mobile cardiac telemetry (MCT) market.
Data Bridge Market Research analyses that the Middle East and Africa Mobile cardiac telemetry (MCT) market, which was USD 1,278.18 million in 2022, is expected to reach USD 1,976.53 million by 2030, and is expected to undergo a CAGR of 5.30% during the forecast period of 2023-2030. “Lead based” dominates the technology segment of Middle East and Africa mobile cardiac telemetry (MCT) market owing to the advancements in technology. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Middle East and Africa Mobile Cardiac Telemetry (MCT) Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Technology (Lead Based, Patch Based), Type (Multi-Channel, Single Channel), Cellular Connection (Wireless (WIFI), Bluetooth (BT)), End User (Home Healthcare, Hospitals, Independent Diagnostic Testing Facility (IDTF), Cardiac Centres, Ambulatory Surgical Centres) |
|
Countries Covered |
Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA) |
|
Market Players Covered |
BioTelemetry, Inc. (now part of Royal Philips) (U.S.), iRhythm Technologies, Inc. (U.S.), Medicomp Inc. (U.S.), Bardy Diagnostics, Inc.(U.S.), Preventice Solutions, Inc. (U.S.), InfoBionic, Inc. (U.S.), CardioNet, LLC (U.S.), ZOLL Medical Corporation (U.S.), Biotricity Inc. (U.S.), Bioteque America, (U.S.), Medicomp Medical Data Systems (U.S.), Preventis GmbH (Germany), Applied Cardiac Systems, Inc (U.S.), ScottCare Corporation (U.S.), Medtronic plc ( Ireland), Hill-Rom Holdings, Inc. (U.S.), Biotronik SE & Co. KG (Germany), GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Spacelabs Healthcare, Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
Mobile cardiac telemetry (MCT) is a medical monitoring technology that allows continuous and remote monitoring of a patient's cardiac activity. It is a portable device that records and transmits real-time data about the patient's heart rhythm and other relevant parameters. MCT is particularly useful in detecting and diagnosing cardiac arrhythmias and other cardiac conditions that may not be captured by traditional holter monitors or event recorders.
Middle East and Africa Mobile Cardiac Telemetry (MCT) Market Dynamics
Drivers
- Increasing Prevalence of Cardiovascular Diseases
The rising incidence of cardiovascular diseases, such as arrhythmias, atrial fibrillation, and heart failure, is a significant driver for the Middle East and Africa mobile cardiac telemetry (MCT) market. MCT devices provide continuous monitoring of a patient's cardiac activity, allowing for early detection and timely intervention in case of abnormalities.
- Growing Demand for Remote Patient Monitoring
The shift towards remote patient monitoring is a major driver for the Middle East and Africa mobile cardiac telemetry (MCT) market. MCT devices enable real-time monitoring of cardiac activity outside of clinical settings, allowing patients to go about their daily activities while still being monitored. This remote monitoring approach reduces the need for hospital visits, improves patient comfort, and facilitates early detection of cardiac events.
- Aging Population and Lifestyle Changes
The aging population and lifestyle changes, such as sedentary lifestyles and unhealthy dietary habits, contribute to the increasing incidence of cardiovascular diseases. This demographic shift and associated risk factors drive the demand for cardiac monitoring solutions such as MCT devices.
Opportunities
- Increasing Awareness and Education
Growing awareness about the benefits of continuous cardiac monitoring and the importance of early detection of cardiac abnormalities is driving the demand for MCT devices. Educational initiatives by healthcare providers, patient advocacy groups, and medical device manufacturers contribute to increased awareness and adoption of MCT technology.
- Technological Advancements in MCT Devices
Continuous advancements in MCT device technology have led to the development of more compact, user-friendly, and accurate devices. These devices offer improved monitoring capabilities, longer battery life, and enhanced connectivity options, making them more convenient for patients and healthcare providers.
Restraints/Challenges
- Regulatory Challenges and Compliance Requirements
MCT devices and services are subject to regulatory requirements and compliance standards, which can pose challenges for manufacturers and healthcare providers. Obtaining necessary approvals and ensuring adherence to regulations can be time-consuming and costly. Compliance with data privacy and security regulations is also crucial due to the sensitive nature of patient cardiac data collected by MCT devices.
-
High Cost of MCT Devices and Services
The cost of MCT devices and associated monitoring services can be a significant restraint for widespread adoption. These devices are often expensive, and the continuous monitoring services may incur additional costs. This can limit the accessibility of MCT technology, particularly in regions with limited healthcare budgets or populations with financial constraints.
This Middle East and Africa mobile cardiac telemetry (MCT) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa mobile cardiac telemetry (MCT) market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In February 2021, Bardy Diagnostics announced the launch of the CAM Patch, an MCT device that provides extended monitoring for up to 14 days. The CAM Patch is discreet, water-resistant, and designed to improve patient compliance and comfort during monitoring
- In January 2021, Medicomp introduced its latest MCT device, the TelePatch. This device offers continuous ECG monitoring and real-time transmission of data for remote patient monitoring. It is designed to be comfortable, easy to use, and compatible with various mobile devices
Middle East and Africa Mobile Cardiac Telemetry (MCT) Market Scope
The Middle East and Africa mobile cardiac telemetry (MCT) market is segmented on the basis of type, technology, cellular connection and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Lead Based
- Patch Based
Type
- Multi-Channel
- Single Channel
- Cellular
Cellular Connection
- Wireless (WIFI)
- Bluetooth (BT)
End-User
- Home Healthcare
- Hospitals
- Independent Diagnostic Testing Facility (IDTF)
- Cardiac Centres
- Ambulatory Surgical Centres
Middle East and Africa Mobile Cardiac Telemetry (MCT) Market Regional Analysis/Insights
The Middle East and Africa mobile cardiac telemetry (MCT) market is analyzed and market size insights and trends are provided by country, type, technology, cellular connection and end-user as referenced above.
The countries covered in the Middle East and Africa mobile cardiac telemetry (MCT) market report are Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
South Africa dominates the Middle East and Africa mobile cardiac telemetry (MCT) market and is expected to witness significant growth during the forecast period of 2023 to 2030, because of the rise in prevalence of cardiovascular disease and growing demand for remote patient monitoring.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Middle East and Africa mobile cardiac telemetry (MCT) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Middle East and Africa mobile cardiac telemetry (MCT) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Middle East and Africa mobile cardiac telemetry (MCT) market. The data is available for historic period 2015-2020.
Competitive Landscape and Middle East and Africa Mobile Cardiac Telemetry (MCT) Market Share Analysis
The Middle East and Africa mobile cardiac telemetry (MCT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Middle East and Africa mobile cardiac telemetry (MCT) market.
Some of the major players operating in the Middle East and Africa mobile cardiac telemetry (MCT) market are:
- BioTelemetry, Inc. (now part of Royal Philips) (U.S.)
- iRhythm Technologies, Inc. (U.S.)
- Medicomp Inc. (U.S.)
- Bardy Diagnostics, Inc.(U.S.)
- Preventice Solutions, Inc. (U.S.)
- InfoBionic, Inc. (U.S.)
- CardioNet, LLC (U.S.)
- ZOLL Medical Corporation (U.S.)
- Biotricity Inc. (U.S.)
- Bioteque America, (U.S.)
- Medicomp Medical Data Systems (U.S.)
- Preventis GmbH (Germany)
- Applied Cardiac Systems, Inc(U.S.)
- ScottCare Corporation (U.S.)
- Medtronic plc( Ireland)
- Hill-Rom Holdings, Inc. (U.S.)
- Biotronik SE & Co. KG (Germany)
- GE Healthcare (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Spacelabs Healthcare, Inc. (U.S.)
SKU-
